Today is the 20th National HIV Testing Day, a time to act by promoting HIV testing and early diagnosis across the United States. The theme of this annual action day—Take the Test. Take Control.—sends the message that it is time to step up, get tested, and know your status. When a person knows his or her HIV status, they are more likely to take steps to protect their own health and that of their partners.
Dr. Jonathan Mermin, Director of CDC's Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, talks about how Pre-Exposure Prophylaxis or PrEP for HIV prevention is a powerful new tool that has the potential to alter the course of HIV in the United States.
Dr. Jonathan Mermin, Director of CDC's Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, discusses the key points of CDC's new Guidelines on the use of Pre-Exposure Prophylaxis or PrEP for HIV prevention.
New on AIDS.gov: Campaigns page. A quick guide to current federal HIV & viral hepatitis awareness, prevention, care, and research campaigns.
Dear Colleague Letter about National Women and Girls HIV/AIDS Awareness Day (NWGHAAD) by HHS Office on Women’s Health Director Nancy C. Lee, M.D.
Learn about how drug use and HIV are related, the HIV risks of different types of drugs, reducing your risk of HIV infection if you use drugs, and the importance of HIV testing for people who use drugs.
Each year on World AIDS Day, we come together as a global community to fight a devastating pandemic. We remember the friends and loved ones we have lost, stand with the estimated 35 million people living with HIV/AIDS, and renew our commitment to preventing the spread of this virus at home and abroad. If we channel our energy and compassion into science-based results, an AIDS-free generation is within our reach.
When the World Health Organization established the first World AIDS Day on December 1, 1988, treatment options for people living with HIV were practically nonexistent, and AIDS was almost invariably fatal. Hope was in short supply, and there seemed to be little reason for optimism. I am grateful that the world is a very different place for the 25th annual World AIDS Day.
As a result, the information on this website may not be up to date, the transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at http://www.usa.gov.
New research by scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, reveals how HIV triggers a signal telling an infected immune cell to die. This finding has implications for preserving the immune systems of HIV-infected individuals.
Learn more on AIDS.gov's page "Hepatitis". Read http://aids.gov/hiv-aids-basics/staying-healthy-with-hiv-aids/potential-related-health-problems/hepatitis/
May is Hepatitis Awareness Month. Check it out. Read http://aids.gov/news-and-events/hepatitis/
Learn more about the Action Plan for the Prevention Care and Treatment of Viral Hepatitis. Read http://aids.gov/news-and-events/hepatitis/
UPDATED: We’ve updated our page, Addressing the Cost of HIV Care in our Find Care and Treatment topic area.
Since 2006, the Centers for Disease Control and Prevention (CDC) has recommended routine HIV testing-i.e., that patients be tested as a routine part of care and be told they will be tested unless they decline. This approach aims to expand testing to a wider patient population and increase testing rates.
On December 1, World AIDS Day, we remember those we have lost, but also celebrate the remarkable progress made in the global fight against HIV/AIDS. When the first World AIDS Day was observed in 1988, we could not imagine the end of the HIV/AIDS epidemic. For those diagnosed with HIV infection, the future was bleak.
To help stop the spread of HIV and sexually transmitted diseases (STDs), the Indian Health Service (IHS) supported the development of a Tribal HIV/STD Training Kit and Policy Guide. The training kit gives tribes and tribal organizations information on how to work with tribal council members, school boards, health directors, and other partnering programs on ways to prevent the transmission of HIV and STDs.
Today, the U.S. Food and Drug Administration approved Truvada (emtricitabine/tenofovir disoproxil fumarate), the first drug approved to reduce the risk of HIV infection in uninfected individuals who are at high risk of HIV infection and who may engage in sexual activity with HIV-infected partners. Truvada, taken daily, is to be used for pre-exposure prophylaxis (PrEP) in combination with safer sex practices to reduce the risk of sexually-acquired HIV infection in adults at high risk.
AIDS.gov adds new page on Employment in the Staying Healthy with HIV section. Content provided by our partners at the U.S. Department of Labor.